Find Publications
Refine your search by selecting items below:
Quebec: An outbreak of HIV/AIDS-related stigma and discrimination – HIV/AIDS Policy & Law Review 9(1), August 2004
In the space of a few weeks in January 2004, actions by three different institutions in Quebec combined to threaten the human rights of people living with HIV/AIDS, raise the spectre of mandatory HIV testing, and create unnecessary public fears about the spread of HIV infection. In response to what they called “the worst weeks … Read more
HIV/AIDS and Pharmaceutical Pricing
This info sheet is one in a series of seven info sheets on the federal regulation of pharmaceutical prices in Canada. Health Spending and the Pharmaceutical Industry Controlling Medicine Prices: Evolution of Canadian Law Patented Medicine Prices Review Board Preventing Excessive Pricing of Patented Medicines Jurisdiction of the PMPRB Pricing of HIV/AIDS Drugs Trends in … Read more
HIV/AIDS and the Privacy of Health Information
This is a series of seven info sheets: The Importance of Privacy of Health Information for People Living with HIV/AIDS Privacy, Confidentiality, and Privilege: Related Legal Concepts Legal Protection of Privacy and Confidentiality in Canadian Law Privacy Principles Limits on Privacy and Confidentiality of Health Information Patient Confidentiality and Preventing Harm to Others Privacy Protection … Read more
Letter to the Standing Committee on Industry, Science and Technology re: Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act
“I write to follow up on our previous submissions to the Standing Committee regarding Bill C-9, Canada’s laudable initiative to implement the WTO General Council Decision of August 30, 2003 to enable countries lacking sufficient pharmaceutical manufacturing capacity to ‘make effective use’ of compulsory licensing to obtain lower cost generic pharmaceutical products manufactured in Canada…”
Letter to the Standing Committee on Industry, Science and Technology re: Bill C-9 and the issue of NGO procurement of Canadian-made phramaceuticals
“As was requested by the Committee when we appeared before you on February 26, 2004, we have provided the Committee with our supplementary submissions regarding the alternatives to the ‘right of refusal’ that had been proposed to the Committee… “However, discussions at subsequent Committee meetings have indicated that Committee members are under a fundamental misapprehension … Read more
Global Access to Medicines: Will Canada Meet the Challenge? – Supplementary submission to the Standing Committee on Industry, Science and Technology regarding Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act
The Standing Committee has asked that we provide our views regarding the “alternatives” to the right of refusal that have been put forward by other witnesses appearing before the Committee. We address several of the most important points that have been put before the Committee.
Disclosure of HIV Status After Cuerrier: Resources for Community Based AIDS Organizations
This resource guide is intended to provide concise, accurate information and practical tools so that people living with HIV/AIDS (PHAs) and community based AIDS organizations (CBAOs) can make informed and empowered choices about how to respond to the complex legal and ethical issues related to HIV disclosure.
Stories of Community Mobilization
This report presents seven stories of community mobilization. They include: Improving Relations Between the GLBT Community and the Ottawa Police; Fighting to Keep Disability Benefits in Ontario; Addressing Barriers that Put Women in B.C. at Risk; Building a Sense of Connection, Belonging, and Esteem through the International Two-Spirit Gathering Movement; Fighting for a Supervised Injection … Read more
Network News 14 – March 2004
In this issue: Network Challenges Montréal Archbishop – And Wins! Canada’s Drug Patent Act Amendment Consultation on Sex Work Submission on sexual orientation to UN Commission on Human Rights Dublin Declaration on HIV/AIDS in Prisons Community Mobilization Workshop Microbicide, Treatment and Vaccine Advocacy Deadly Public Policy Inside the Network Coming Soon Feedback New Resources
Page 87 of 100